Ameet Sarpatwari, JD, PhD

Ameet Sarpatwari is an Instructor in Medicine at Harvard Medical School and an Associate Epidemiologist at Brigham and Women’s Hospital based in the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics. His research draws upon his interdisciplinary training as an epidemiologist and lawyer and focuses on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes. Among other projects, he is currently examining the public health implications of variation in state drug product selection laws, the risk of re-identification under HIPAA pathways for data sharing for post-approval drug research, and the comparative safety and effectiveness of biosimilars.


Posts by Ameet Sarpatwari, JD, PhD

Why many generic drugs are becoming so expensive

Ameet Sarpatwari, JD, PhD
Ameet Sarpatwari, JD, PhD, Contributing Editor

Generic drugs used to be a reliable lower-cost alternative to many brand-name drugs. But thanks to a combination of market forces, the cost of many generics is rising quickly — and steeply. This trend will increase the burden of health care costs for insurers, governments, and individuals. Find out why this is happening, as well as what you can do to help sidestep these costs and advocate for policies that can stem this tide.